Lastly, in colorectal cancer cells, replacement of miR-194 results in this miRNA targeting HMGA2 coexpressed genes through the TGFβ signaling pathway and this decreases cell viability in response to oxaliplatin and irinotecan [191]. The gene discussed is HMGA2; the disease is colorectal cancer.